NELFE
Negative elongation factor E
Also known as: D6S45, NELF-E, NELFE_HUMAN, RD, RDBP, RDP
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P18615
- Gene
- NELFE
- Ensembl
- ENSG00000204356
- Chromosome
- 6
- Canonical length
- 380 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nuclear bodies
OverviewNCBI Gene
The protein encoded by this gene is part of a complex termed negative elongation factor (NELF) which represses RNA polymerase II transcript elongation. This protein bears similarity to nuclear RNA-binding proteins; however, it has not been demonstrated that this protein binds RNA. The protein contains a tract of alternating basic and acidic residues, largely arginine (R) and aspartic acid (D). The gene localizes to the major histocompatibility complex (MHC) class III region on chromosome 6. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
380 residues, UniProt reviewed canonical sequence.
>P18615|NELFE
1 MLVIPPGLSE EEEALQKKFN KLKKKKKALL ALKKQSSSST TSQGGVKRSL SEQPVMDTAT
61 ATEQAKQLVK SGAISAIKAE TKNSGFKRSR TLEGKLKDPE KGPVPTFQPF QRSISADDDL
121 QESSRRPQRK SLYESFVSSS DRLRELGPDG EEAEGPGAGD GPPRSFDWGY EERSGAHSSA
181 SPPRSRSRDR SHERNRDRDR DRERDRDRDR DRDRERDRDR DRDRDRDRER DRDRERDRDR
241 DREGPFRRSD SFPERRAPRK GNTLYVYGED MTPTLLRGAF SPFGNIIDLS MDPPRNCAFV
301 TYEKMESADQ AVAELNGTQV ESVQLKVNIA RKQPMLDAAT GKSVWGSLAV QNSPKGCHRD
361 KRTQIVYSDD VYKENLVDGFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NELFE can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.57
- Highest tissue expression
- 151 nTPM
Expression across tissuesHPA
Tissue
- testis: 151 nTPM
- blood vessel: 57 nTPM
- heart muscle: 53 nTPM
- skeletal muscle: 52 nTPM
- pancreas: 50 nTPM
- kidney: 49 nTPM
Single-cell type
- late spermatids: 2,521 nCPM
- late primary spermatocytes: 601 nCPM
- early spermatids: 578 nCPM
- oocytes: 152 nCPM
- gastric progenitor cells: 144 nCPM
- fallopian tube ciliated cells: 140 nCPM
Immune cell
- intermediate monocyte: 69 nTPM
- non-classical monocyte: 68 nTPM
- classical monocyte: 61 nTPM
- eosinophil: 59 nTPM
- myeloid DC: 57 nTPM
- total PBMC: 55 nTPM
Brain region
- thalamus: 18 nTPM
- white matter: 18 nTPM
- hypothalamus: 18 nTPM
- medulla oblongata: 17 nTPM
- spinal cord: 16 nTPM
- cerebellum: 16 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.56
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 1.57
- DepMap mean gene effect
- -0.42
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of transcription by RNA polymerase II
- negative regulation of transcription elongation by RNA polymerase II
- positive regulation of ERK1 and ERK2 cascade
- positive regulation of transcription by RNA polymerase II
- transcription pausing by RNA polymerase II
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- RNA recognition motif domain
- Nucleotide-binding alpha-beta plait domain superfamily
- RNA-binding domain superfamily
- RNA recognition motif
- Negative elongation factor E
- Negative elongation factor E, RNA recognition motif
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NELFE in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NELFE as an antibody target. Whether an autoantibody or antibody against NELFE could matter depends on whether native NELFE is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NELFE is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NELFE as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...